ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
14.87
-1.08 (-6.77%)
At close: Oct 30, 2026, 4:00 PM EDT
14.85
-0.02 (-0.13%)
After-hours: Oct 30, 2026, 7:30 PM EDT
ArriVent BioPharma Employees
ArriVent BioPharma had 77 employees as of December 31, 2025. The number of employees increased by 25 or 48.08% compared to the previous year. That makes ArriVent BioPharma the 32,978th largest employer in the world and 4,290th in the United States.
Employees
77
Change (1Y)
25
Growth (1Y)
48.08%
Revenue / Employee
n/a
Profits / Employee
-$2,132,597
Market Cap
733.21M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 77 | 25 | 48.08% |
| Dec 31, 2024 | 52 | 12 | 30.00% |
| Dec 31, 2023 | 40 | - | - |
| Sep 30, 2023 | 42 | - | - |
| Jun 30, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Ardelyx | 489 |
| Wave Life Sciences | 317 |
| 4D Molecular Therapeutics | 196 |
| Sana Biotechnology | 142 |
| Helus Pharma | 100 |
| Annexon | 92 |
| OmniAb | 89 |
AVBP News
- 4 days ago - ArriVent Biopharma price target raised to $30 from $18 at Guggenheim - TheFly
- 4 days ago - ArriVent Biopharma price target raised to $21 from $18 at Truist - TheFly
- 4 days ago - ArriVent Biopharma price target raised to $25 from $18 at Oppenheimer - TheFly
- 4 days ago - ArriVent Biopharma announces initial Phase 1 results for ARR-217 - TheFly
- 5 days ago - ArriVent BioPharma Transcript: Study update - Transcripts
- 5 days ago - ArriVent BioPharma Press release: Study update - Filings
- 5 days ago - ArriVent BioPharma Slides: Study update - Filings
- 5 days ago - ArriVent cancer data support ‘best-in-class’ potential, says Clear Street - TheFly